Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of GBP 91.45 billion. The enterprise value is 108.15 billion.

Market Cap	91.45B
Enterprise Value	108.15B

Important Dates

The next estimated earnings date is Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.69%
Shares Change (QoQ)	-0.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.28B

Valuation Ratios

The trailing PE ratio is 27.69.

PE Ratio	27.69
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.12, with an EV/FCF ratio of 25.53.

EV / Earnings	32.74
EV / Sales	4.04
EV / EBITDA	14.12
EV / EBIT	20.42
EV / FCF	25.53

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.58.

Current Ratio	1.84
Quick Ratio	1.17
Debt / Equity	0.58
Debt / EBITDA	3.00
Debt / FCF	5.15
Interest Coverage	8.51

Financial Efficiency

Return on equity (ROE) is 8.61% and return on invested capital (ROIC) is 5.30%.

Return on Equity (ROE)	8.61%
Return on Assets (ROA)	4.53%
Return on Capital (ROIC)	5.30%
Revenue Per Employee	267,535
Profits Per Employee	34,768
Employee Count	95,000
Asset Turnover	0.37
Inventory Turnover	2.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.99% in the last 52 weeks. The beta is 0.85, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+1.99%
50-Day Moving Average	84.17
200-Day Moving Average	84.17
Relative Strength Index (RSI)	70.26
Average Volume (20 Days)	10,682

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.48

Income Statement

In the last 12 months, Medtronic had revenue of GBP 25.42 billion and earned 3.30 billion in profits. Earnings per share was 2.52.

Revenue	25.42B
Gross Profit	16.62B
Operating Income	5.02B
Pretax Income	3.97B
Net Income	3.30B
EBITDA	7.06B
EBIT	5.02B
Earnings Per Share (EPS)	2.52

Full Income Statement

Balance Sheet

The company has 6.15 billion in cash and 21.82 billion in debt, giving a net cash position of -15.66 billion.

Cash & Cash Equivalents	6.15B
Total Debt	21.82B
Net Cash	-15.66B
Net Cash Per Share	n/a
Equity (Book Value)	37.52B
Book Value Per Share	29.12
Working Capital	7.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.54 billion and capital expenditures -1.31 billion, giving a free cash flow of 4.24 billion.

Operating Cash Flow	5.54B
Capital Expenditures	-1.31B
Free Cash Flow	4.24B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.40%, with operating and profit margins of 19.77% and 13.00%.

Gross Margin	65.40%
Operating Margin	19.77%
Pretax Margin	15.62%
Profit Margin	13.00%
EBITDA Margin	27.77%
EBIT Margin	19.77%
FCF Margin	16.67%

Dividends & Yields

This stock pays an annual dividend of 2.18, which amounts to a dividend yield of 2.47%.

Dividend Per Share	2.18
Dividend Yield	2.47%
Dividend Growth (YoY)	-0.85%
Years of Dividend Growth	n/a
Payout Ratio	84.54%
Buyback Yield	1.69%
Shareholder Yield	4.16%
Earnings Yield	3.61%
FCF Yield	4.63%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.81
Piotroski F-Score	n/a